Nu-derm System Normal-oily Kit
NDC Package 62032-533-60

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Nu-derm System Normal-oily (hydroquinone, homosalate, octisalate, and zinc oxide) kits is for the gradual bleaching of hyperpigmented skin conditions such as chloasma, melasma, freckles, senile lentigines and other unwanted areas of melanin hyperpigmentation. This formulation utilizes a kit delivery system. Marketed by Obagi Cosmeceutical Llc, this product is identified by NDC 62032-533.

Identification & Billing

NDC Package Code
62032-533-60
Package Description
1 KIT in 1 KIT * 59 mL in 1 BOTTLE, PLASTIC * 28 g in 1 BOTTLE, PLASTIC * 57 g in 1 BOTTLE, PLASTIC * 28 g in 1 BOTTLE, PLASTIC * 59 mL in 1 BOTTLE, PLASTIC * 85 g in 1 TUBE
Product Code
62032-533
11-Digit Billing Format
62032053360
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Nu-derm System Normal-oily Skin Transformation Trial
Non-Proprietary Name
Hydroquinone, Homosalate, Octisalate, And Zinc Oxide
Dosage Form
Kit - A packaged collection of related material.
Usage Information
For the gradual bleaching of hyperpigmented skin conditions such as chloasma, melasma, freckles, senile lentigines and other unwanted areas of melanin hyperpigmentation.

Regulatory & Marketing

Labeler Name
Obagi Cosmeceutical Llc
Product Type
Human Prescription Drug
Marketing Category
UNAPPROVED DRUG OTHER - An unapproved drug product in a marketing category that is not reflected on a particular list.
Start Marketing Date
12-02-2019
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 62032-533-60 identifies a specific commercial package of 1 kit in 1 kit * 59 ml in 1 bottle, plastic * 28 g in 1 bottle, plastic * 57 g in 1 bottle, plastic * 28 g in 1 bottle, plastic * 59 ml in 1 bottle, plastic * 85 g in 1 tube of Nu-derm System Normal-oily Skin Transformation Trial, a human prescription drug labeled by Obagi Cosmeceutical Llc. This kit is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Obagi Cosmeceutical Llc on December 02, 2019. The current certification is valid through December 31, 2026.

How is this Obagi Cosmeceutical Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 62032053360. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
62032-533-60
11-Digit CMS (5-4-2)
62032-0533-60

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.